MORGAN CARTER: Open Payments
NPI 1003550336 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 46 payments from 26 companies in 2025. Trend: 2023 $497 · 2024 $1,884 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $210 |
| Celgene Corporation | 4 | $83 |
| Janssen Biotech, Inc. | 4 | $77 |
| ABBVIE INC. | 3 | $51 |
| BeiGene USA, Inc. | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Genentech USA, Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Incyte Corporation | 1 | $28 |
| TerSera Therapeutics LLC | 1 | $24 |
Products named: REBLOZYL, KISQALI, SCEMBLIX, EPKINLY, Fabhalta, KEYTRUDA, LUTATHERA, IMFINZI.
Industry payments across AL — which companies pay providers there.
